Previous in vivo studies showed that CA-170 promoted activation and proliferation of a subset of T cells whose activity was impaired by PD-L1 or VISTA [91], and inhibited tumor growth in multiple mouse syngeneic cancer models [92]. Here, VSIR is linked to neoplasm.